Strategies to Improve the Safety of iPSC-Derived ß Cells for ß Cell Replacement in Diabetes.
Transpl Int
; 35: 10575, 2022.
Article
in En
| MEDLINE
| ID: mdl-36090777
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pluripotent Stem Cells
/
Diabetes Mellitus
/
Insulin-Secreting Cells
/
Induced Pluripotent Stem Cells
Type of study:
Guideline
Limits:
Humans
Language:
En
Journal:
Transpl Int
Journal subject:
TRANSPLANTE
Year:
2022
Document type:
Article
Affiliation country:
Italy
Country of publication:
Switzerland